KEVIN BUSH: Open Payments
NPI 1114913332 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,100 in 138 payments from 22 companies in 2025. Trend: 2023 $2,905 · 2024 $3,153 · 2025 $3,100
Food & beverage: $2,829Education: $271
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $455 |
| ABBVIE INC. | 19 | $418 |
| Regeneron Healthcare Solutions, Inc. | 11 | $320 |
| GENZYME CORPORATION | 8 | $279 |
| Arcutis Biotherapeutics, Inc. | 7 | $237 |
| UCB, Inc. | 19 | $226 |
| Lilly USA, LLC | 8 | $156 |
| Incyte Corporation | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| Organon LLC | 3 | $140 |
Products named: DUPIXENT, TREMFYA, Zoryve, Bimzelx, SKYRIZI, RINVOQ, OPZELURA, COSENTYX.
Industry payments across GA — which companies pay providers there.
